RxDoctor Payments Data

Kyle Fiala, DPM

Foot & Ankle Surgery · Columbia, MONPI 1013246701

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (24.1%), education and royalties or licence payments — rather than concentrated in one kind of arrangement. 18 manufacturers reported payments, led by Fusion Orthopedics USA, LLC at 27.8% of the total.

$37,383in general payments, 2019–2025

Across 85 payments — averaging $439.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Fusion Orthopedics USA, LLC$10K
  • Arthrex$9K
  • Synthes GmbH$7K
  • Elite Orthopedics, LLC$6K
  • Stryker$1K
  • Fusion Orthopedics, LLC.$1K
  • plus $2K from 12 others

What the payments were for

  • Royalty or licence$7,10819%
  • Consulting fees$4,80013%
  • Speaking & faculty fees$9,00024%
  • Travel & lodging$5,45715%
  • Food & beverage$3,3239%
  • Education$7,69421%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$37,383 in reported general payments places this provider in the 85th percentile of 163 foot & ankle surgery providers in Missouri.

See all foot & ankle surgery providers in Missouri

Medicare billing

Part B allowed, 2024
$61,775
Medicare patients
205
Services billed
422

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Cephalexin13$121
Meloxicam22$14

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in Columbia

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →